Expression and significance of soluble fms-like tyrosine kinase-1 in preeclampsia
Lu Mu
Abstract
Lu Mu
Abstract
Objective:To explore whether soluble fms-like tyrosine kinase-1(sFlt-1) can be used as a serum marker to predict preeclampsia.Methods:Electrochemiluminescence was used to detect the changes of sFlt-1 levels during different periods of pregnancy in cases with preeclampsia and the cases in control group.Results:In normal control group,the level of sFlt-1 decreased slightly and then increased with gestational weeks;the expression level of serum sFlt-1 in preeclampsia group was significantly higher than that in normal control group(P0.05).Conclusion:The decrease of serum sFlt-1 can be used as an effective clinical index for the patients with preeclampsia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore whether soluble fms-like tyrosine kinase-1(sFlt-1) can be used as a serum marker to predict preeclampsia.Methods:Electrochemiluminescence was used to detect the changes of sFlt-1 levels during different periods of pregnancy in cases with preeclampsia and the cases in control group.Results:In normal control group,the level of sFlt-1 decreased slightly and then increased with gestational weeks;the expression level of serum sFlt-1 in preeclampsia group was significantly higher than that in normal control group(P0.05).Conclusion:The decrease of serum sFlt-1 can be used as an effective clinical index for the patients with preeclampsia.
Key concepts: Preeclampsia, Soluble fms-like tyrosine kinase-1, Medicine, Tyrosine kinase, Pregnancy, Gestational hypertension, Gestational age, Placental growth factor